Illness	Number of cases
Malignant melanoma of skin (C43.5)	112
Malignant melanoma of skin (C43.7)	95
Malignant neoplasm without specification of site - Disseminated malignant neoplasm unspecified (C80.0)	49
Malignant melanoma of skin (C43.6)	38
Malignant melanoma of skin - Malignant melanoma of scalp and neck (C43.4)	31
Malignant melanoma of skin (C43.2)	13
Malignant neoplasm of other connective and soft tissue - Malignant neoplasm of connective and soft tissue of thorax (C49.3)	12
Malignant neoplasm of penis - Malignant neoplasm of penis unspecified (C60.9)	11
Malignant melanoma of skin (C43.3)	8
Other malignant neoplasms of skin (C44.7)	7

Top 10 treatments

Treatment	Number
Others therapeutic procedures to influence the immune system (8-547.0)	166
(6-008.m6)	126
Cancer treatment for several days (e.g. 2-4 days) with two or more chemotherapy drugs administered into a vein (8-543.22)	56
Others therapeutic procedures to influence the immune system (8-547.2)	56
(6-007.5)	49
(6-009.7)	49
(9-984.7)	35
(9-984.8)	35
Cancer treatment for several days (e.g. 2-4 days) with two or more chemotherapy drugs administered into a vein (8-543.31)	34
(6-008.m2)	27

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0500

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ28

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
27	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
18	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
9	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities	Hautklinik der Universität Köln und Universitätsklinikum Münster (Herr Priv.-Doz. Dr. H.-J. Schulze); Universitätsklinikum Münster (Herr Uni.-Prof. Dr. T. Hirsch, Herr Priv.-Doz. Dr. M. Kückelhaus); Charité- Universitätsmedizin Berlin (Priv.-Doz. Dr. Dr. J. D. Raguse)
Student training (clinical traineeship / internship year)	Doktoranden Ausbildung Medizinische Fakultät der WWU in MS ; PJ Wahlfach Plastische Chirurgie der WWU Münster
Project-related cooperation with colleges and universities	Universitätsklinikum Münster;Universitäts-Hautklinik; Sozialmedizin der Universitätsklinik Heidelberg; Plastische Chirurgie und Biophysik, Ruhr-Universität Bochum, Charité-Universitätsmedizin Berlin,Yale Medical School,Harvard Medical, Universität Bremen
Participation in multi-centre Phase I/II studies	Melanom (GO40558) Merkelzell-Carcinom (EMR100070-003-Studie, ADMEC-Studie), Plattenepithelkarzinom (AliCe), advanced Melanoma, c-SCC, hn-SCC, ACC (Cure-Vac)
Participation in multi-centre phase III/IV studies	Melanom (COLUMBUS-Studie, Trilogy, COMBI-EU, NivoPass,CA045-001,Starboard, Harmony, PIVOT-12,NivoMela, BERING) Basaliom (NISSO), Merkelzellkarzinom (MCC Trim), Plattenepithelkarzinom (cemiSkin)
Initiation and management of uni-centric/multi-centric clinical/scientific studies	NOLC Neck Dissektion and outcome in Lipcancer; Lymphknotendissektion der Leiste in d.Chirurgie mal.Hauttumore; Mucograft Langzeit Follow Up; IR-Imaging (Melanom, Basaliom)
Editors of scientific journals/textbooks	Best Practice Oncology (Herr Priv.-Doz. Dr. H.-J. Schulze)
Doctoral supervision	Westfälische Wilhelms-Universität Münster; Humboldt-Universität Berlin; Universität Köln; Ruhr-Universität Bochum

Training

No.	Training in other healing professions	Comment
HB01	Nurse and health care worker (m/f)	Kooperation mit den LWL Kliniken Münster und der St. Hildegard GmbH Münster
HB19	Nursing professionals	Kooperation mit den LWL Kliniken Münster und der St. Hildegard GmbH Münster
HB07	Surgical technical assistant (m/f)	Kooperation mit der Franziskus-Gesundheitsakademie Münster